| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Stuelpnagel John R is a Director at 10x Genomics, Inc.. Recent SEC Form 4 filings include 0 buys and 54 sells.
Estimated insider holdings value: $7.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $183.18 | $1,373,887.25 | -0.2% | |
| Feb 16, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $193.00 | $1,447,515.54 | -0.2% | |
| Feb 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $176.05 | $1,320,379.67 | -0.3% | |
| Jan 19, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $178.76 | $1,340,699.22 | -0.2% | |
| Jan 4, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $139.86 | $1,048,981.81 | -0.4% | |
| Dec 16, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $148.21 | $1,111,583.09 | -0.3% | |
| Dec 1, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $151.23 | $1,134,228.29 | -0.3% | |
| Nov 17, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $135.98 | $1,019,862.03 | -0.4% | |
| Nov 2, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $136.36 | $1,022,664.65 | -0.4% | |
| Oct 16, 2020 | TXG 10x Genomics, Inc. | Director | Sell | 7,500 | $164.26 | $1,231,936.43 | -0.7% |